Orthotopic Bone Formation by Streamlined Engineering and Devitalization of Human Hypertrophic Cartilage
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Most bones of the human body form and heal through endochondral ossification, whereby hypertrophic cartilage (HyC) is formed and subsequently remodeled into bone. We previously demonstrated that HyC can be engineered from human mesenchymal stromal cells (hMSC), and subsequently devitalized by apoptosis induction. The resulting extracellular matrix (ECM) tissue retained osteoinductive properties, leading to ectopic bone formation. In this study, we aimed at engineering and devitalizing upscaled quantities of HyC ECM within a perfusion bioreactor, followed by in vivo assessment in an orthotopic bone repair model. We hypothesized that the devitalized HyC ECM would outperform a clinical product currently used for bone reconstructive surgery. Human MSC were genetically engineered with a gene cassette enabling apoptosis induction upon addition of an adjuvant. Engineered hMSC were seeded, differentiated, and devitalized within a perfusion bioreactor. The resulting HyC ECM was subsequently implanted in a 10-mm rabbit calvarial defect model, with processed human bone (Maxgraft®) as control. Human MSC cultured in the perfusion bioreactor generated a homogenous HyC ECM and were efficiently induced towards apoptosis. Following six weeks of in vivo implantation, microcomputed tomography and histological analyses of the defects revealed an increased bone formation in the defects filled with HyC ECM as compared to Maxgraft®. This work demonstrates the suitability of engineered devitalized HyC ECM as a bone substitute material, with a performance superior to a state-of-the-art commercial graft. Streamlined generation of the devitalized tissue transplant within a perfusion bioreactor is relevant towards standardized and automated manufacturing of a clinical product.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853 · cited 1×
“We may speculate that the apoptosis induction, generating apoptotic bodies instead of uncontrolled organelles release through necrosis, may lead to attenuated immune response [25].”
BackgroundAn overview of tissue and whole organ decellularization processes
Crapo, P. M., Gilbert, T. W., & Badylak, S. F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.057 · Cited by 3,591 · cited 1×
“To bypass an autologous setting and enable an off-the-shelf solution, the engineered HyC could be devitalized, leading to an extracellular matrix (ECM) embedding the cytokines capable to activate the process of EO [12,13].”
BackgroundFracture healing: mechanisms and interventions
Einhorn, T. A., & Gerstenfeld, L. C. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.164 · Cited by 1,807 · cited 2×
“For example, the efficiency of bone formation in specific critical settings could be increased by engineering cells overexpressing cytokines known to enhance the rate of HyC remodeling, the ingrowth of vasculature or the polarization of inflammatory/immune cells [4,34,35].”
BackgroundConcise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells
Lv, F.-J., Tuan, R. S., Cheung, K. M. C., & Leung, V. Y. L. (2014) · Stem Cells · doi:10.1002/stem.1681 · Cited by 984 · cited 1×
“Additionally, there is currently no reliable marker allowing to predict the potential of hMSC preparations to form HyC [30].”
BackgroundBone remodeling during fracture repair: The cellular picture
Schindeler, A., McDonald, M. M., Bokko, P., & Little, D. G. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.004 · Cited by 961 · cited 1×
“For example, the efficiency of bone formation in specific critical settings could be increased by engineering cells overexpressing cytokines known to enhance the rate of HyC remodeling, the ingrowth of vasculature or the polarization of inflammatory/immune cells [4,34,35].”
BackgroundBMP signalling in skeletal development, disease and repair
Salazar, V. S., Gamer, L. W., & Rosen, V. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.12 · Cited by 822 · cited 3×
“, bone morphogenetic protein 2 (BMP2) [27]) cytokines.”
The roles of vascular endothelial growth factor in bone repair and regeneration
Hu, K., & Olsen, B. R. (2016) · Bone · doi:10.1016/j.bone.2016.06.013 · Cited by 678 · cited 3×
“Sci. 2020, 21, 7233 11 of 14 genes: Glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Hs02758991_g1), Indian Hedge Hog (IHH, Hs01081800_m1), SRY-box 9 (SOX9, Hs00165814_m1), Matrix metalloproteinase 13 (MMP13, Hs00233992_m1), Collagen type II (ColII, Hs00264051_m1), Collagen type X (ColX, Hs00166657_m1), Vascular endot…”
BackgroundFernandez-Yague, M. A., Abbah, S. A., McNamara, L., Zeugolis, D. I., Pandit, A., & Biggs, M. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.005 · Cited by 523 · cited 1×
“In some critical cases, however, spontaneous bone healing is not sufficient and surgical intervention using graft substitutes is required [1].”
BackgroundOrgan engineering based on decellularized matrix scaffolds
Song, J. J., & Ott, H. C. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.005 · Cited by 501 · cited 1×
“To bypass an autologous setting and enable an off-the-shelf solution, the engineered HyC could be devitalized, leading to an extracellular matrix (ECM) embedding the cytokines capable to activate the process of EO [12,13].”
BackgroundScotti, C., Tonnarelli, B., Papadimitropoulos, A., Scherberich, A., Schaeren, S., Schauerte, A., Lopez-Rios, J., Zeller, R., Barbero, A., & Martin, I. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000302107 · Cited by 477 · cited 3×
“The cytofluorimetric profile of the expanded cells corresponds to what was previously reported [7].”
BackgroundMethodResultSelf-citation
Cited by
Kasravi, M., Ahmadi, A., Babajani, A., Mazloomnejad, R., Hatamnejad, M. R., Shariatzadeh, S., Bahrami, S., & Niknejad, H. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00348-z · Cited by 316
Recent approaches towards bone tissue engineering
Maia, F. R., Bastos, A. R., Oliveira, J. M., Correlo, V. M., & Reis, R. L. (2022) · Bone · doi:10.1016/j.bone.2021.116256 · Cited by 94
Fu, L., Li, P., Li, H., Gao, C., Yang, Z., Zhao, T., Chen, W., Liao, Z., Peng, Y., Cao, F., et al. (2021) · Stem Cells International · doi:10.1155/2021/6621806 · Cited by 75
“[28] hBM-MSCs Human MSCs cultured in the perfusion bioreactor Perfusion bioreactors Generated a homogeneous hypertrophic cartilage ECM; efficiently induced towards apoptosis”
BackgroundMethodYamada, S., Ockermann, P., Schwarz, T., Mustafa, K., & Hansmann, J. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.08.008 · Cited by 17
Cheng, C., Chaaban, M., Born, G., Martín, I., Li, Q., Schaefer, D. J., Jaquiéry, C., & Scherberich, A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.841690 · Cited by 14
Metadata
- Authors
- Pigeot, S., Bourgine, P. E., Claude, J., Scotti, C., Papadimitropoulos, A., Todorov, A., Epple, C., Peretti, G. M., & Martin, I.
- Affiliations
- University of Basel (CH)
- Department of Surgery, University Hospital Basel, University of Basel, 4031 Basel, Switzerland
- IRCCS Ospedale Galeazzi - Sant'Ambrogio (IT)
- University of Milan (IT)
- Department of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-09-30
- Volume
- 21
- Issue
- 19
- Pages
- 7233
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7582540
- OpenAlex
- W3089985264
- Cited by
- 15
- References
- 40
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 2
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Eurostars Program (E!7865)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030-133110)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hypertrophic cartilage, extracellular matrix, endochondral ossification, mesenchymal stem cells, apoptosis induction, perfusion bioreactor, bone substitutes, calvarial defect, rabbit model, tissue engineering, bone regeneration
- MeSH terms
- Animals, Cartilage, Cell Differentiation, Extracellular Matrix, Humans, Osteogenesis, Rabbits, Skull, Wound Healing, Bone Remodeling, Apoptosis, Bone Substitutes, Tissue Engineering, Mesenchymal Stem Cell Transplantation, Tissue Scaffolds, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Orthotopic Bone Formation by Streamlined Engineering and Devitalization of Human Hypertrophic Cartilage. https://app.cochat.ai/papers/10.3390/ijms21197233
- The paper
- Pigeot, S., Bourgine, P. E., Claude, J., Scotti, C., Papadimitropoulos, A., Todorov, A., Epple, C., Peretti, G. M., & Martin, I. (2020). Orthotopic Bone Formation by Streamlined Engineering and Devitalization of Human Hypertrophic Cartilage. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21197233
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.